Healthcare - Medical - Care Facilities - NASDAQ - US
$ 9.81
-2 %
$ 323 M
Market Cap
-196.2
P/E
INCOME STATEMENT
2.02 B
REVENUE
113 M
OPERATING INCOME
72.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Cross Country Healthcare, Inc.
| Revenue | 2.02 B |
| Cost Of Revenue | 1.59 B |
| Gross Profit | 432 M |
| Operating Expenses | 338 M |
| Operating Income | 113 M |
| Other Expenses | 40.1 M |
| Net Income | 72.6 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 2 019.7 | 2 806.6 | 1 676.7 | 836.4 | 822.2 | 816.5 | 865.0 | 833.5 | 767.4 | 617.8 | 438.3 | 442.6 | 504.0 | 468.6 | 578.2 | 734.2 | 718.3 | 655.2 | 645.4 | 654.1 | 686.9 | 640.0 | 500.5 | 367.7 | 193.8 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 1 587.7 | 2 178.9 | 1 301.7 | 633.7 | 618.2 | 606.9 | 636.5 | 611.8 | 570.1 | 460.0 | 324.9 | 331.1 | 366.0 | 336.2 | 420.9 | 541.7 | 543.6 | 502.5 | 503.1 | 509.6 | 520.0 | 478.5 | 374.7 | 273.1 | 148.2 |
| Gross Profit | 432.1 | 627.7 | 375.0 | 202.7 | 204.0 | 209.6 | 228.6 | 221.7 | 197.4 | 157.8 | 113.5 | 111.6 | 137.9 | 132.3 | 157.4 | 192.6 | 174.7 | 152.7 | 142.3 | 144.5 | 167.0 | 161.4 | 125.9 | 94.6 | 45.6 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 337.7 | 336.8 | 225.1 | 186.5 | 196.0 | 192.0 | 197.6 | 189.0 | 169.3 | 148.5 | 112.3 | 116.6 | 127.4 | 121.2 | 138.0 | 392.7 | 132.6 | 124.5 | 112.6 | 108.0 | 119.0 | 102.7 | 87.4 | 65.8 | 176.1 |
| Selling, General and Administrative Expenses | 315.0 | 324.2 | 215.3 | 173.8 | 182.0 | 180.2 | 187.4 | 179.8 | 161.3 | 141.0 | 106.1 | 109.4 | 116.5 | 109.0 | 124.8 | 137.8 | 124.3 | 110.6 | 106.0 | 100.5 | 110.9 | 95.2 | 69.7 | 49.5 | 21.9 |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 112.7 | 273.1 | 139.3 | 16.0 | 8.0 | (12.9) | 11.7 | 6.2 | 20.6 | (10.5) | (8.0) | (24.5) | 10.5 | 0.4 | 17.7 | (200.1) | 42.0 | 28.2 | 29.7 | 36.6 | 48.0 | 58.7 | 38.4 | 28.8 | 17.7 |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 8.1 | 14.4 | 6.9 | 2.9 | 5.3 | 5.7 | 4.2 | 6.1 | 6.8 | 4.2 | 0.8 | 2.3 | 2.9 | 4.1 | 6.2 | 4.2 | 2.6 | 1.5 | 3.5 | 4.0 | 4.3 | 3.8 | 14.4 | 15.4 | 0 |
| Total Other Income | (9.8) | (16.8) | (6.1) | (3.2) | (8.5) | (5.3) | (7.4) | (1.6) | (16.4) | (20.9) | (2.0) | (2.4) | (2.3) | 38.3 K | (8.1) | (248.2) | (2.7) | (1.5) | (4.8) | (4.0) | (5.3) | (3.7) | (22.4) | (15.4) | (5.2) |
| Pre-Tax Income | 102.9 | 256.3 | 133.2 | (12.3) | (24.2) | (18.2) | 4.3 | 4.5 | 4.2 | (31.3) | (10.0) | (26.9) | 8.2 | (3.8) | 11.7 | (204.2) | 39.3 | 26.7 | 24.9 | 32.5 | 42.7 | 54.9 | 24.0 | 13.4 | 12.4 |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | 30.3 | 67.9 | 1.2 | (0.2) | 31.7 | (2.5) | (34.5) | (4.2) | (0.8) | 0.2 | 26.8 | (6.2) | 4.1 | (1.0) | 5.0 | (61.2) | 14.8 | 10.1 | 9.6 | 11.9 | 16.5 | 21.3 | 10.4 | 6.7 | 0.7 |
| Net Income | 72.6 | 188.5 | 132.0 | (12.1) | (55.9) | (17.0) | 37.5 | 8.0 | 4.4 | (31.8) | (34.6) | (42.2) | 4.1 | (2.8) | 6.7 | (142.9) | 24.6 | 16.6 | 14.8 | 20.7 | 25.8 | 29.8 | 8.7 | 4.6 | 11.5 |
| EPS | 2.07 | 5.09 | 3.6 | 0.34 | 1.56 | 0.48 | 1.07 | 0.25 | 0.14 | 1.02 | 1.12 | 1.37 | 0.13 | 0.0893 | 0.22 | 4.64 | 0.77 | 0.52 | 0.46 | 0.65 | 0.8 | 0.92 | 0.35 | 0.2 | 0.75 |